AMPH logo

AMPH

Profile

Full Name

Amphastar Pharmaceuticals, Inc.

Ticker Symbol

AMPH

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

June 25, 2014

Indexes

Not included

Website

http://www.amphastar.com

Employees

2028

Key Details

Price

$23.50(-3.77%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$731.97M(+13.59% YoY)

Annual EPS

$3.06(+17.69% YoY)

PE ratio

7.68

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$23.50
AMPH price is $23.50

30-Day Relative Volume

1.17
AMPH 30-day relative volume is 1.17

Price Performance

Price Most recent change

-3.77%
AMPH price was down -3.77% on Apr 15, 2025

Price YTD change

-36.71%
AMPH price is down -36.71% since January 1st

Price 1-year change

-42.37%
AMPH price is down -42.37% year-on-year

Price 3-year change

-43.43%
AMPH price is down -43.43% over the past 3 years

Price Range

Price All-time high

$67.66
AMPH price is currently -65.27% below its historical high of $67.66

Price 3-year low

$22.74
AMPH price is currently +3.34% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.12B
AMPH market capitalization is $1.12 billion

Market cap 3-year change

-44.77%
AMPH market capitalization is down -44.77% over the past 3 years

Market cap All-time high

$3.14B
AMPH market capitalization is currently -64.33% below its historical high of $3.14 billion

Market cap sector rank

77.63%
AMPH market capitalization is higher than 77.63% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-2.49%
AMPH shares outstanding is down -2.49% year-on-year

Shares Outstanding 3-Year Change

-2.38%
AMPH shares outstanding is down -2.38% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.61
AMPH beta is 0.61

200-day SMA

$39.85
AMPH price is currently -41.04% below its 200-day simple moving average

50-day SMA

$28.70
AMPH price is currently -18.12% below its 50-day simple moving average

RSI

31.76
AMPH 14-day relative strength index is 31.76

Volume

1.17
AMPH 30-day relative volume is 1.17

ATR

$1.22
AMPH average true range is $1.22

10-day Historical Volatility

64.91%
AMPH 10-day historical volatility is 64.91%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$731.97M
AMPH annual revenue is $731.97 million

Revenue Analysts estimate

$732.58M
AMPH annual revenue is currently -0.08% lower than the consensus analysts' forecast

Revenue 1-year change

+13.59%
AMPH annual revenue is up +13.59% year-on-year

Revenue Sector rank

77.99%
AMPH annual revenue is higher than 77.99% of companies in Healthcare sector

EPS

EPS

$3.06
AMPH annual earnings per share is $3.06

EPS Analysts estimate

$3.17
AMPH annual earnings per share is currently -3.57% lower than the consensus analysts' forecast

EPS 1-year change

+17.69%
AMPH annual earnings per share is up +17.69% year-on-year

EPS Sector rank

93.95%
AMPH annual earnings per share is higher than 93.95% of companies in Healthcare sector

Profit

Gross profit

$373.86M
AMPH annual gross profit is $373.86 million

Gross margin

51.08%
AMPH annual gross profit margin is 51.08%

Operating profit

$205.42M
AMPH annual operating income is $205.42 million

Operating margin

28.06%
AMPH annual operating profit margin is 28.06%

Net income

$159.52M
AMPH annual net profit is $159.52 million

Net margin

21.79%
AMPH annual net profit margin is 21.79%

Expenses

Total expenses

$526.55M
AMPH annual total expenses is $526.55 million

Operating expenses

$168.44M
AMPH annual total operating expenses is $168.44 million

Cost of goods sold

$358.11M
AMPH annual cost of goods sold is $358.11 million

Selling, general & administrative expenses

$94.52M
AMPH annual SGA is $94.52 million

Depreciation and amortization

$57.20M
AMPH annual depreciation & amortization is $57.20 million

Interest expense

$30.34M
AMPH annual interest expense is $30.34 million

Income tax

$29.67M
AMPH annual income tax is $29.67 million

EBIT & EBITDA

EBIT

$220.11M
AMPH annual earnings before interest & taxes is $220.11 million

EBITDA

$220.11M
AMPH annual EBITDA is $220.11 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.58B
AMPH annual total assets is $1.58 billion

Non current assets

$1.04B
AMPH annual long term assets is $1.04 billion

Current assets

$534.07M
AMPH annual total current assets is $534.07 million

Cash and cash equivalents

$151.61M
AMPH annual cash & cash equivalents is $151.61 million

Accounts receivable

$136.29M
AMPH annual accounts receivable is $136.29 million

Inventory

$153.74M
AMPH annual inventory is $153.74 million

Liabilities

Total liabilities

$845.17M
AMPH annual total liabilities is $845.17 million

Long term liabilities

$671.41M
AMPH annual total long term liabilities is $671.41 million

Current liabilities

$173.76M
AMPH annual total current liabilities is $173.76 million

Accounts payable

$30.51M
AMPH annual accounts payable is $30.51 million

Debt

Total debt

$650.55M
AMPH annual total debt is $650.55 million

Total debt 1-year change

+4.31%
AMPH annual total debt is up +4.31% year-on-year

Long term debt

$643.51M
AMPH annual long term debt is $643.51 million

Short term debt

$7.04M
AMPH annual short term debt is $7.04 million

Equity & Capital

Shareholders equity

$732.30M
AMPH annual stockholders equity is $732.30 million

Book value

$732.30M
AMPH annual book value is $732.30 million

Retained earnings

$568.79M
AMPH annual retained earnings is $568.79 million

Working capital

$360.31M
AMPH annual working capital is $360.31 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$213.39M
AMPH annual cash flow from operations is $213.39 million

Cash from operations 1-year change

+16.28%
AMPH annual cash flow from operations is up +16.28% year-on-year

Cash from investing

-$124.93M
AMPH annual cash flow from investing activities is -$124.93 million

Cash from investing 1-year change

+80.75%
AMPH annual cash flow from investing activities is up +80.75% year-on-year

Cash from financing

-$80.95M
AMPH annual cash flow from financing activities is -$80.95 million

Cash from financing 1-year change

-117.83%
AMPH annual cash flow from financing activities is down -117.83% year-on-year

CAPEX

CAPEX

$41.04M
AMPH annual capital expenditures is $41.04 million

CAPEX 1-year change

+7.53%
AMPH annual capital expenditures is up +7.53% year-on-year

Free Cash Flow

Free cash flow

$172.34M
AMPH annual free cash flow is $172.34 million

Free cash flow 1-year change

+18.58%
AMPH annual free cash flow is up +18.58% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

51.08%
AMPH annual gross profit margin is 51.08%

Operating margin

28.06%
AMPH annual operating profit margin is 28.06%

Net margin

21.79%
AMPH annual net profit margin is 21.79%

ROA & ROE

ROA

10.32%
AMPH annual return on assets is 10.32%

ROE

23.26%
AMPH annual return on equity is 23.26%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

7.68
AMPH price to earnings ratio is 7.68

PE ratio Sector rank

10.29%
AMPH price to earnings ratio is higher than 10.29% of companies in Healthcare sector

PB Ratio

PB ratio

1.53
AMPH price to book ratio is 1.53

PB ratio Sector rank

56.13%
AMPH price to book ratio is higher than 56.13% of companies in Healthcare sector

PS Ratio

PS ratio

1.53
AMPH price to sales ratio is 1.53

PS ratio Sector rank

36.54%
AMPH price to sales ratio is higher than 36.54% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.62B
AMPH enterprise value is $1.62 billion

Enterprise value Sector rank

79.9%
AMPH enterprise value is higher than 79.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

6.16
AMPH EV/EBITDA is 6.16

EV/EBITDA Sector rank

79.11%
AMPH EV/EBITDA is higher than 79.11% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.07
AMPH annual current ratio is 3.07

Quick ratio

2.19
AMPH annual quick ratio is 2.19

Leverage

Debt to equity

0.82
AMPH annual debt to equity ratio is 0.82

Interest coverage ratio

7.25
AMPH annual interest coverage ratio is 7.25

Risk & Stability

Piotroski F-Score

6
AMPH piotroski f-score is 6

Altman Z-Score

2.50
AMPH altman z-score is 2.50

Analyst ratings

Recent major analysts updates

Apr 10, 25 Needham
Hold
Mar 21, 25 Piper Sandler
Neutral
Feb 4, 25 Piper Sandler
Neutral
Nov 22, 24 Wells Fargo
Overweight
Aug 8, 24 Piper Sandler
Overweight
Aug 8, 24 Needham
Hold
Jun 27, 24 Piper Sandler
Overweight
May 22, 24 Needham
Hold
May 9, 24 Needham
Hold
Apr 10, 24 Needham
Hold

Institutional Ownership

Similar stocks

ARDX logo
Ardelyx (ARDX)
INVA logo
Innoviva (INVA)
Indivior (INDV)
MD logo
Pediatrix Medical (MD)
PLSE logo
Pulse Biosciences (PLSE)
FNA logo
Paragon 28 (FNA)
Kestra Medical Technologies (KMTS)
ADPT logo
Adaptive Biotechnologies (ADPT)
PCRX logo
Pacira BioSciences (PCRX)
  • What is the ticker symbol for Amphastar Pharmaceuticals?
  • Does Amphastar Pharmaceuticals pay dividends?
  • What sector is Amphastar Pharmaceuticals in?
  • What industry is Amphastar Pharmaceuticals in?
  • What country is Amphastar Pharmaceuticals based in?
  • When did Amphastar Pharmaceuticals go public?
  • Is Amphastar Pharmaceuticals in the S&P 500?
  • Is Amphastar Pharmaceuticals in the NASDAQ 100?
  • Is Amphastar Pharmaceuticals in the Dow Jones?
  • When was Amphastar Pharmaceuticals's last earnings report?
  • When does Amphastar Pharmaceuticals report earnings?
  • Should I buy Amphastar Pharmaceuticals stock now?

What is the ticker symbol for Amphastar Pharmaceuticals?

The ticker symbol for Amphastar Pharmaceuticals is NASDAQ:AMPH

Does Amphastar Pharmaceuticals pay dividends?

No, Amphastar Pharmaceuticals does not pay dividends

What sector is Amphastar Pharmaceuticals in?

Amphastar Pharmaceuticals is in the Healthcare sector

What industry is Amphastar Pharmaceuticals in?

Amphastar Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Amphastar Pharmaceuticals based in?

Amphastar Pharmaceuticals is headquartered in United States

When did Amphastar Pharmaceuticals go public?

Amphastar Pharmaceuticals's initial public offering (IPO) was on June 25, 2014

Is Amphastar Pharmaceuticals in the S&P 500?

No, Amphastar Pharmaceuticals is not included in the S&P 500 index

Is Amphastar Pharmaceuticals in the NASDAQ 100?

No, Amphastar Pharmaceuticals is not included in the NASDAQ 100 index

Is Amphastar Pharmaceuticals in the Dow Jones?

No, Amphastar Pharmaceuticals is not included in the Dow Jones index

When was Amphastar Pharmaceuticals's last earnings report?

Amphastar Pharmaceuticals's most recent earnings report was on Feb 27, 2025

When does Amphastar Pharmaceuticals report earnings?

The next expected earnings date for Amphastar Pharmaceuticals is May 8, 2025

Should I buy Amphastar Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page